GSK
GLAXOSMITHKLINE PLC ORD 25P
Stock London Stock Exchange – Stock Market Prices, News & Analysis
GlaxoSmithKline est une entreprise pharmaceutique mondiale, active dans la recherche, le développement, la fabrication et la distribution de médicaments, vaccins et produits de santé grand public.
GLAXOSMITHKLINE PLC ORD 25P
GSK
GlaxoSmithKline est une entreprise pharmaceutique mondiale, active dans la recherche, le développement, la fabrication et la distribution de médicaments, vaccins et produits de santé grand public.
Price history of GLAXOSMITHKLINE PLC ORD 25P
Price history of GLAXOSMITHKLINE PLC ORD 25P
Performance & Momentum
Strategic Analysis
GLAXOSMITHKLINE PLC ORD 25P • 2026
GlaxoSmithKline is a global pharmaceutical player positioned on an integrated model combining innovative medicines, vaccines, and consumer healthcare. Its strength lies in its expertise in medical research and sectoral diversification that enables it to meet various healthcare needs.
Strengths
- Diversified portfolio including vaccines, medicines, and consumer products
- Sustained innovation capability supported by significant investments in R&D
- Global presence with a strong foothold in the UK and efficient coverage of key markets
Weaknesses
- Exposure to strict regulations and pressures on drug pricing
- Dependence on a few flagship products for a significant share of revenue
Momentum
The momentum is strong, driven by positive dynamics over multiple time horizons, reflecting renewed investor confidence in the strategic repositioning and resilience of the group, despite a demanding competitive and regulatory environment.
Similar stocks to GLAXOSMITHKLINE PLC ORD 25P
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
